CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
6.12
-0.64 (-9.47%)
At close: May 12, 2026, 4:00 PM EDT
6.13
+0.01 (0.16%)
Pre-market: May 13, 2026, 7:49 AM EDT
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $4.97 million as of May 13, 2026. Its market cap has increased by 60.63% in one year.
Market Cap
4.97M
Enterprise Value
-1.91M
1-Year Change
60.63%
Ranking
Category
Stock Price
$6.12
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $4.97M, a decrease of -92.90%. That is a compound annual growth rate of -33.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 4.97M | 52.50% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptevo Therapeutics | 5.71M |
| Clearmind Medicine | 5.50M |
| Cardio Diagnostics Holdings | 5.39M |
| Bio Green Med Solution | 5.19M |
| BiomX | 5.04M |
| BioRestorative Therapies | 5.03M |
| MetaVia | 5.01M |
| Enveric Biosciences | 5.00M |